Cardiosense, Inc., Completes .1 Million Sequence A Financing to Advance Synthetic Intelligence Platform for Coronary heart Illness

Cardiosense, Inc., Completes $15.1 Million Sequence A Financing to Advance Synthetic Intelligence Platform for Coronary heart Illness

CHICAGO, Dec. 8, 2022 /PRNewswire/ — Cardiosense, Inc., a Chicago-based digital well being firm leveraging synthetic intelligence and multi-sensor gadgets to allow early detection of heart problems, introduced at the moment that it has raised $15.1 million in Sequence A funding, co-led by Broadview Ventures and Hatteras Enterprise Companions, with participation from Laerdal Million Lives Fund, […]

Continue Reading